arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Progyny, Inc.

PGNY
$25.82 ▼ -0.41 (-1.56%) at close
Healthcare ·Services-Misc Health & Allied Services, NEC ·USServices-Misc Health & Allied Services, NEC
35 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
69
Health
Good
Neutral
auto_awesome

Analytical Summary

Progyny, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $2.0B
Dividend Yield
Revenue Growth 5.3%
Op. Margin 11.4%
ROIC 6.0%
FCF / Share $0.57
Trailing P/E 71.7x
Price / Book 4.4x
FCF Yield 2.2%
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

35-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$350.51M
↑ +5.3%
Net Income Profit after all expenses
$28.05M
↑ +63.9%
Operating Margin Operating profit as % of sales
11.4%
↑ +6.0% 47th
FCF / Share Free cash flow per share
$0.57
↑ +15.6%

Health Breakdown

Profitability
56
Returns
72
Cash Quality
92

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 9 years · 35 quarters